Abstract: Provided is a pixel structure, a display panel, and a display device. The pixel structure includes three sub-pixel units of different colors and a driving unit. The three sub-pixel units include a first sub-pixel unit, a second sub-pixel unit, and a third sub-pixel unit. The driving unit is configured to send corresponding display data to the three sub-pixel units respectively. The sub-pixel units are arranged on one side or two sides of the driving unit.

Abstract: A Lactobacillus paracasei and uses thereof. The Lactobacillus paracasei has a deposit number of CGMCC No. 14813. The Lactobacillus paracasei can be used for increasing the amount of an organic acid in a raw material. The Lactobacillus paracasei can be used for fermenting the raw material, where the raw material can be selected from at least one of fruits, which can increase the content of the organic acid in a fermented product.

Abstract: A compound comprising the amino acid sequence: W-Lys-X1-Ser-U-X2-Y-G wherein W, X1, U, X2 and Y and G have meanings given in the description, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said peptide compounds. The compounds arc particularly useful in the treatment of conditions characterized by inflammation. including wounds. burns, and disorders of the mucosa. such as anorectal diseases, inflammatory bowel diseases. gynaecological diseases and dental diseases.

Abstract: Provided is a modified peptide compound comprising one or more of the peptide components (a), (b) or (c): (a) a peptide component of formula I, A-Q-B I A and B represent Z or represent A1-1-B1, A1 and B1 independently represent Z or A2-Q2-B2, A2 and B2 independently represent Z or Z-Q3-Z, Q1, Q2 and Q3 represent, for example, Lys and Z represents a peptide component of the amino acid sequence: [W-Lys-X1-Ser-U-X2-Y] n-W-Lys-X1-Ser-U-X2-Y- (SEQ ID No: 3) (b) a peptide component of the amino acid sequence: [Ala-Lys-X1-Ser-U-X2-Y] p-Ala-Lys-X1-Ser-U-X2-Y-G (SEQ ID No: 4); or (c) a peptide component of the amino acid sequence: W1-Lys-X1-Ser-U1-X2-Y-G (SEQ ID No: 5) wherein: n p, W, W1, X1, U, U1, X2, Y and G have meanings given in the description, and wherein the peptide component is modified to include a labelling groups or labelling components that is/are capable of medical imaging of internal regions of the body non-invasively, and/or of diagnosing and/or therapeutically treating one or more diseases (such as c

Abstract: Provided are a conjugate formed between an anaesthetic compound and a peptide component of the amino acid sequence: W-Lys-X1-Ser-U-X2-Y, wherein: W, X1, U, X2 and Y are as defined in the description, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said conjugates, which conjugates are useful in the treatment of conditions characterised by inflammation and/or of pain. Preferred anaesthetics are local anaesthetics, such as procaine.

Abstract: Provided is a peptide compound comprising the amino acid sequence: G-W-Lys-X1-Ser-U-X2-Y-Z-Q wherein: G represents an optional N-terminal a 3,4-dihydrocinnamic acid group; W represents Ala or Ser, or is absent; U represents Tyr, DOPA or a single bond; X1 and X2 independently represent Pro, Hyp or diHyp; Y represents a single bond or represents a 1 to 5 amino acid sequence, in which the amino acids are selected from one or more of the group Pro, Hyp, diHyp, Thr, DOPA and Tyr; Z represents Pro, Hyp, diHyp, Thr, DOPA or Tyr; and Q represents Lys or is absent, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said peptide compound, provided that when G is not present, W represents Ala or is absent and Q represents Lys, then Z represents Pro, Hyp, diHyp or Thr.

Abstract: There is provided topical pharmaceutical formulations comprising montelukast, or a pharmaceutical acceptable salt of solvate thereof, as well as combination products comprising (a) at least one mussel adhesive protein or a derivative thereof; and (b) montelukast, or a pharmaceutically-acceptable salt or solvate thereof. The formulations and combination products find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.

Abstract: A display device include a first light emitting diode (LED), a second LED, and at least one processor of a driver. The processor drives the first LED and the second LED. The processor determines a first pulse width associated with the first LED and a second pulse width associated with the second LED based on a level of brightness to be emitted by the first LED and the second LED. The processor also receives a gap clock and determines a first pulse start time and a first pulse end time for the first LED based on the first pulse width. Moreover, the processor determines a second pulse start time and a second pulse end time for the second LED based on the first pulse end time, the second pulse width, and/or the gap clock, in which the first pulse end time and the second pulse end time are different.

Abstract: There is provided a peptide-containing compound that comprises a peptide component which is an amino acid sequence of from 2 to 45 (e.g. from 6 to 15) amino acids, which peptide component is covalently bonded to one or more compounds of the formula I: wherein: R1 is selected from the group consisting of —C(CH3)2OH, —COCH3, —C(CH3)?CH2 and —C(CH3)2H; and n is 0, 1 or 2, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said peptide-containing compound. The compound of formula I is preferably montelukast, montelukast styrene or hydrogenated montelukast styrene. The peptide-containing compound is particularly useful in the treatment of conditions characterised by inflammation, including wounds, hemorrhoids, burns, psoriasis, acne, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, chronic obstructive pulmonary disease, inflammatory bowel disease (such as ulcerative colitis).

Abstract: Light emitting diode display panels with an open loop amplifier resulting in better brightness accuracy and matching between multiple light emitting diode strings.

Abstract: There is provided a compound of formula (I), A-Q-B I wherein Q represents a structural fragment of formula (II), wherein: the squiggly lines and m have meanings given in the description, and wherein A and B have meanings given in the description, but may represent a peptide component of the amino acid sequence: [W-Lys-X1-Ser-U—X2—Y]n—W-Lys-X1-Ser-U—X2—Y— (SEQ ID No: 3) wherein the dashed line, n, W, X1, U, X2 and Y have meanings given in the description, which compounds are useful in medicine, including as pharmaceutical excipients, adhesives and film-forming materials and/or are useful in the treatment of conditions characterised by inflammation, including wounds, burns, and disorders of the mucosa, such as anorectal diseases, inflammatory bowel diseases, gynaecological diseases and dental diseases.

Abstract: An integrated system for automatic forming, picking, and inspection of a grinding wheel mesh piece and a method thereof, including a visual inspection system (1), a conveying system (2), a cutting system (3), and a picking system (4); the conveying system (2) is used to precisely control a conveying action of a cutting section conveying platform (51) and a picking section conveying platform (52), and the visual inspection system (1) is used to acquire an image of a grinding wheel mesh cloth, establish virtual origin coordinates of a cutting layout and center coordinates of the grinding wheel mesh piece after cutting, recognize defects of the grinding wheel mesh cloth, and calibrate qualified center coordinates and unqualified center coordinates; the cutting system (3) is used to cut the grinding wheel mesh cloth moved to the cutting section conveying platform (51) to obtain a circular grinding wheel mesh piece.

Abstract: A semiconductor memory comprising: a comparison readout circuit comprising a first port configured to receive an electric signal of a read memory unit and a second port configured to receive a reference electric signal, the comparison readout circuit being configured to compare the electric signal of the read memory unit with the reference electric signal to obtain storage information of the memory unit; and a first/second column decoder connected to a first/second memory array and the comparison readout circuit and configured to select a bitline corresponding to the read memory unit when a memory array selection signal enables the first/second memory array, and output the electric signal of the memory unit to the first port by means of the bitline, and further configured to connect a first bitline of the first/second memory array to the second port when the memory array selection signal does not enable the first/second memory array.

Abstract: Systems and methods for preserving a pulse width modulation (PWM) resolution while increasing the frequency of a pulse width modulation (PWM) clock are provided. An electronic display backlight system may include a backlight element and backlight dimming circuitry. The backlight element may be driven according to a pulse width modulation (PWM) signal over a PWM clock cycle equal to a multiple M of a baseline PWM clock frequency associated with a baseline PWM resolution. The backlight dimming circuitry may receive a brightness code of the baseline PWM resolution and generate the PWM signal at least in part by dividing the brightness code by M.

Abstract: There is provided a peptide-containing compound that comprises a peptide component which is an amino acid sequence of from 2 to 45 (e.g. from 6 to 15) amino acids, which peptide component is covalently bonded to one or more compounds of formula I: wherein: R1 is selected from the group consisting of —C(CH3)2OH, —COCH3, —C(CH3)?CH2 and —C(CH3)2H; and n is 0, 1 or 2, as well as regioisomers, stereoisomers, and pharmaceutically- or cosmetically-acceptable salts of said peptide-containing compound. The compound of formula I is preferably montelukast, montelukast styrene or hydrogenated montelukast styrene. The peptide-containing compound is particularly useful in the treatment of conditions characterised by inflammation, including wounds, hemorrhoids, burns, psoriasis, acne, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, chronic obstructive pulmonary disease, inflammatory bowel disease (such as ulcerative colitis).

Abstract: There is provided topical pharmaceutical formulations comprising montelukast, or a pharmaceutical acceptable salt of solvate thereof, as well as combination products comprising (a) at least one mussel adhesive protein or a derivative thereof; and (b) montelukast, or a pharmaceutically-acceptable salt or solvate thereof. The formulations and combination products find particular utility in direct topical administration for the treatment of inflammation, of inflammatory disorders and/or of condition characterized by inflammation, including wounds, burns, psoriasis, acne and atopic dermatitis.

Abstract: A method and an apparatus related to network analysis are provided. A work topology is mapping into an abstract topology according to a workload's network behavior. The network behavior is defined by a connection of the workload via one or more ingress ports and/or one or more egress target ports. The work topology records one or more ingress ports or one or more egress target ports supported by the workload. The abstract topology records a dynamic relationship of the currently operating ingress port or egress target port of the workload and a corresponding anomaly rule. The dynamic relationship is compared with the anomaly rule to determine that an abnormal situation occurs on the workload. The abnormal situation is related to a violation of the workload model which comprises static role, dynamic relationship, and the anomaly rule. The dynamic relationship is an associated behavior between the workload and another workload via the ingress ports and/or the egress target ports of the workload.

Abstract: A semiconductor memory, comprising a negative voltage providing unit, which is used for providing a first negative voltage to a word line during a read operation, and comprises: a clamping unit that comprises an input end, a control end and an output end, wherein the input end is coupled to a common ground end of the memory, and the control end is used for receiving a first signal; an energy storage capacitor, a first end of which is coupled to the output end, and a second end that is used for receiving a second signal; and a negative voltage providing end which is coupled to the first end, wherein the clamping unit is used for: pulling the voltage at the output end to the voltage at the input end when the first signal is “0”; and clamping the output end at a clamping voltage when the first signal is “1”.

Abstract: Provided is a conjugate formed between one or more linear polysaccharide chains and a peptide selected from one or more of the peptide components (a), (b), (c) or (d) as defined below: (a) a peptide component of formula (I), A-Q-B I wherein Q represents a structural fragment of formula (II), wherein: the squiggly lines and m have meanings given in the description and A and B have meanings given in the description, but may represent a peptide component of the amino acid sequence: [W-Lys-X1-Ser-U-X2-Y] n-W-Lys-X1-Ser-U-X2-Y--- (SEQ ID No: 3), wherein the dashed line, n, W, X1, U, X2 and Y have meanings given in the description; (b) a peptide component of the amino acid sequence: [Ala-Lys-X1-Ser-U-X2-Y] p-Ala-Lys-X1-Ser-U-X1-Y-G (SEQ ID No: 4) wherein p, G, X1, U, X2 and Y have meanings given in the description; (c) a peptide component of the amino acid sequence: W-Lys-X1-Ser-U-X2-Y-G (SEQ ID No: 5), wherein W, X1, U, X2, Y and G have meanings given in the description; or (d) a peptide component of the amino aci

Abstract: Systems and methods for preserving a pulse width modulation (PWM) resolution while increasing the frequency of a pulse width modulation (PWM) clock are provided. An electronic display backlight system may include a backlight element and backlight dimming circuitry. The backlight element may be driven according to a pulse width modulation (PWM) signal over a PWM clock cycle equal to a multiple M of a baseline PWM clock frequency associated with a baseline PWM resolution. The backlight dimming circuitry may receive a brightness code of the baseline PWM resolution and generate the PWM signal at least in part by dividing the brightness code by M.